**Core Concept**
The C-peptide is a byproduct of proinsulin cleavage during insulin synthesis and secretion by the pancreas. Elevated C-peptide levels are indicative of endogenous insulin production, often seen in conditions where the pancreas is still functioning.

**Why the Correct Answer is Right**
Increased C-peptide levels are seen in conditions where there is residual beta-cell function, such as in type 1 diabetes with residual insulin production, or in type 2 diabetes with preserved beta-cell function. This is in contrast to exogenous insulin administration, where C-peptide levels would be low. The pancreas's ability to produce insulin and C-peptide as a byproduct is a key indicator of its functional status.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because this condition is typically associated with low C-peptide levels due to exogenous insulin administration.
**Option B:** Incorrect because this condition is characterized by high glucose levels and is not directly related to C-peptide production.
**Option C:** Incorrect because this condition is associated with low C-peptide levels due to beta-cell destruction and lack of insulin production.

**Clinical Pearl / High-Yield Fact**
Elevated C-peptide levels can help differentiate between type 1 and type 2 diabetes, particularly in cases where the clinical presentation is unclear. This is an important consideration in the management and treatment of diabetes.

**Correct Answer:** B. Insulinoma.